Skip to main content

Want a detailed portfolio tracker?

Vivani Medical (VANI) P/E (2015 - 2026)

Vivani Medical (VANI) P/E from Sep 30, 2015 to Jul 21, 2026. The TTM Vivani Medical (VANI) P/E is -17.85. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Vivani Medical (VANI)

YearP/EChange
2026-17.85+25.92%
2025-14.18+24.84%
2024-11.36+67.40%
2023-6.78+20.04%
2022-5.65-82.62%
2021-32.53+23.46%
2020-26.34-73.00%
2019-97.56+63.46%
2018-59.69-53.79%
2017-129.15+25.05%
2016-103.28-66.55%
2015-308.80N/A

Comparison Vivani Medical (VANI) P/E with competitors

Vivani Medical (VANI) P/E is -17.85.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.42%
FGENFibroGen Inc0.24-101.34%
CHRSCoherus Biosciences Inc0.85-104.75%
FBIOFortress Biotech Inc0.95-105.32%
ORMPOramed Pharmaceuticals Inc1.50-108.42%
AGENAgenus Inc3.01-116.86%
INVAInnoviva Inc3.15-117.67%
VXRTVaxart Inc3.55-119.88%
CRMDCorMedix Inc3.63-120.32%
CVACCureVac N.V.4.45-124.90%
GLPGGalapagos NV4.86-127.21%
SRPTSarepta Therapeutics Inc4.88-127.34%
ABEOAbeona Therapeutics Inc5.39-130.18%
ABUSArbutus Biopharma Corp5.60-131.34%
ZVRAZevra Therapeutics Inc5.89-132.97%
SPROSpero Therapeutics Inc6.23-134.89%
CGENCompugen Ltd6.31-135.36%
RIGLRigel Pharmaceuticals6.87-138.49%
SLXNSilexion Therapeutics Corp7.30-140.86%
OMEROmeros Corporation9.26-151.86%
AUPHAurinia Pharmaceuticals Inc9.58-153.68%
PLXProtalix BioTherapeutics Inc10.89-161.00%
ACADAcadia Pharmaceuticals Inc11.73-165.69%
TBPHTheravance Biopharma Inc12.26-168.68%
ADMAAdma Biologics Inc12.42-169.55%
HRMYHarmony Biosciences Holdings Inc13.82-177.41%
SABSSAB Biotherapeutics Inc14.14-179.18%
NAGENiagen Bioscience Inc14.82-183.00%
INCYIncyte Corp15.82-188.62%
REGNRegeneron Pharmaceuticals Inc15.86-188.81%
PBYIPuma Biotechnology Inc17.32-196.98%
CPRXCatalyst Pharmaceuticals Inc17.44-197.68%
EXELExelixis Inc17.54-198.23%
TGTXTG Therapeutics Inc18.97-206.23%
MDXGMimedx Group Inc20.55-215.11%
XOMAXOMA Royalty Corp22.87-228.12%
ARGXArgen X SE24.30-236.10%
CTMXCytomX Therapeutics Inc24.82-239.03%
XOMAOXOMA Royalty Corp25.34-241.96%
HALOHalozyme Therapeutics Inc25.62-243.52%
XOMAPXOMA Royalty Corp25.67-243.78%
VRTXVertex Pharmaceuticals Inc27.99-256.80%
RPRXRoyalty Pharma plc - Class A28.69-260.68%
SLNOSoleno Therapeutics Inc29.02-262.52%
ASNDAscendis Pharma A/S30.09-268.51%
LGNDLigand Pharmaceuticals Inc - Class B37.91-312.35%
APLSApellis Pharmaceuticals Inc39.02-318.56%
BMRNBiomarin Pharmaceutical Inc42.21-336.43%
KRYSKrystal Biotech Inc45.34-353.97%
ONCBeiGene Ltd69.54-489.50%
PHARPharming Group N.V.75.03-520.23%
TECHBio-Techne Corp101.96-671.08%
ALNYAlnylam Pharmaceuticals Inc117.96-760.73%
GMABGenmab140.29-885.78%
TLXTelix Pharmaceuticals Ltd162.15-1008.23%
CORTCorcept Therapeutics Inc212.86-1292.24%